Annogen B.V.

Annogen B.V. is an SME in Amsterdam, Netherlands that has taken part in 2 EU-funded projects since 2020, receiving €266k in EU funding.

EU funding received€266k
EU projects2
As coordinator0
Running now1
First EU project2020
Latest project2027
CountryNetherlands
EU registration (PIC)895731854
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Annogen B.V.'s own share of each project, not the project's full budget.

  • Horizon 2020€266k · 1 project
  • Horizon Europe€0 · 1 project

Projects

2 EU-funded projects, newest first. Each links to the official record.

  • cisCODEAssociated partner

    Training a New Generation to Decode the Human Cis-Regulatory Genome

    Horizon Europe · 2027–2030 · Project on CORDIS ↗

  • ENHPATHYPartner

    Molecular basis of human enhanceropathies

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €266ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • cells technologies
  • diabetes
  • mutation
  • oncology
  • personalized medicine
  • synthetic biology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime